Latest Conference Articles

Dr Joseph Alvarnas: PCOC 2021 Brings Together a Wide Variety of Oncology Stakeholders

Dr Joseph Alvarnas: PCOC 2021 Brings Together a Wide Variety of Oncology Stakeholders

September 16th 2021, 12:45pm

Patient-Centered Oncology Care

The Patient-Centered Oncology Care® (PCOC) conference, taking place in a hybrid format September 23-24, 2021, provides a space for oncologists, payers, health care system leaders, and others to delve into different possibilities to improve care, according to Joseph Alvarnas, MD, of City of Hope, editor-in-chief of Evidence-Based Oncology™ and co-chair of the meeting.

Dr Joseph Alvarnas on the Speakers, Sessions to Watch at PCOC 2021

Dr Joseph Alvarnas on the Speakers, Sessions to Watch at PCOC 2021

September 15th 2021, 6:00pm

Patient-Centered Oncology Care

Looking forward to the 10th anniversary of the Patient-Centered Oncology Care® (PCOC) conference, taking place in a hybrid format September 23-24, 2021, Joseph Alvarnas, MD, of City of Hope, editor-in-chief of Evidence-Based Oncology™, and co-chair of the meeting, discusses the takeaways that attendees can expect to hear about in the areas of patient care, payment and quality, and multidisciplinary collaboration among specialists.

Panel Outlines Updates on HF Treatment Developments, Recommendations for Guidelines

Panel Outlines Updates on HF Treatment Developments, Recommendations for Guidelines

September 13th 2021, 4:30pm

Heart in Diabetes

In a panel at the 5th annual Heart in Diabetes Conference, John McMurray, MD, and Javed Butler, MD, highlighted recent pharmacological developments in heart failure (HF) and offered insights on overlooked areas in the field.

Presentation Outlines Long-term CV Risks of Gestational Diabetes

Presentation Outlines Long-term CV Risks of Gestational Diabetes

September 10th 2021, 9:00pm

Heart in Diabetes

A session at the 5th annual Heart in Diabetes Conference highlights the long-term risks of gestational diabetes.

Research Highlights Benefits of Aspirin, Monoclonal Antibody Use in Patients With Diabetes, COVID-19

Research Highlights Benefits of Aspirin, Monoclonal Antibody Use in Patients With Diabetes, COVID-19

September 10th 2021, 7:00pm

Heart in Diabetes

New research presented at the 5th Heart in Diabetes Conference highlights potential therapeutic options for patients with COVID-19 and diabetes.

The Green Environment, Air Pollution, and Respiratory Health

The Green Environment, Air Pollution, and Respiratory Health

September 9th 2021, 1:05pm

ERS: European Respiratory Society

Increasing air pollution and climate change have an impact on respiratory health and mortality, explained speakers in 2 sessions on the environment and respiratory diseases at the European Respiratory Society International Congress 2021.

Evaluating and Addressing Long COVID Symptoms

Evaluating and Addressing Long COVID Symptoms

September 8th 2021, 6:00pm

ERS: European Respiratory Society

Two posters reviewed impairment after COVID-19 infection and the use of pulmonary rehabilitation to address the symptoms.

Gefapixant Associated With Significant Improvements in Chronic Cough

Gefapixant Associated With Significant Improvements in Chronic Cough

September 7th 2021, 9:15pm

ERS: European Respiratory Society

Gefapixant successfully improved quality-of-life and reduced cough severity for patients with chronic cough vs placebo, according to 2 posters.

Considering Sex and Gender Differences in Respiratory Health

Considering Sex and Gender Differences in Respiratory Health

September 7th 2021, 7:00pm

ERS: European Respiratory Society

Health care and research need to do a better job of taking into account sex and gender differences that can affect disease, healthy behaviors, and care delivery, according to speakers at the European Respiratory Society International Congress 2021.

Dr Alexander Mathioudakis Talks About Outcome Measurement Inconsistencies in RCTs on Pneumonia

Dr Alexander Mathioudakis Talks About Outcome Measurement Inconsistencies in RCTs on Pneumonia

September 7th 2021, 6:36pm

ERS: European Respiratory Society

Outcome inconsistency in randomized controlled trials for pneumonia could create issues for interpreting data and compiling research going forward, said Alexander Mathioudakis, MD, MRCP, at the European Respiratory Society annual meeting.